Ayala Pharmaceuticals, Inc. Annual Revenues in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Ayala Pharmaceuticals, Inc. annual/quarterly Revenues history and growth rate from 2017 to 2023.
  • Ayala Pharmaceuticals, Inc. Revenues for the quarter ending June 30, 2023 was $9K, a 76.3% decline year-over-year.
  • Ayala Pharmaceuticals, Inc. Revenues for the twelve months ending June 30, 2023 was $209K.
  • Ayala Pharmaceuticals, Inc. annual Revenues for 2023 was $13K, a 98.1% decline from 2022.
  • Ayala Pharmaceuticals, Inc. annual Revenues for 2022 was $692K.
  • Ayala Pharmaceuticals, Inc. annual Revenues for 2018 was $6.06M, a 49.6% decline from 2017.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13K -$679K -98.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $692K Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2018 $6.06M -$5.97M -49.6% Nov 1, 2017 Oct 31, 2018 10-K 2019-01-11
2017 $12M Nov 1, 2016 Oct 31, 2017 10-K 2019-01-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.